Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134831 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1921242 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1921239 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL117637 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29268645 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL24119147 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1921241 | 1.00 | TDP1 (0.54) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL21959829 | 0.94 | TDP1 (0.58) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29911393 | 0.94 | TDP1 (0.49) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29843131 | 0.94 | TDP1 (0.49) | TDP1MEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 621 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025098875-A1 | ACTIVE COMPOUND COMBINATIONS HAVING INSECTICIDAL/ACARICIDAL PROPERTIES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-15 | — | — | WO | claimed |
| EP-3887354-B1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORP (US) | 2023-01-04 | — | — | EP | claimed |
| US-20220408727-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING FATTY ACIDS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-29 | — | — | US | claimed |
| CN-115379759-A | Pest control method, pest control agent composition, and pest control agent set | 日本曹达株式会社 | 2022-11-22 | — | — | CN | claimed |
| WO-2022224919-A1 | METHOD FOR CONTROLLING DISEASE-TRANSMITTING INSECTS USING CONDENSED HETEROCYCLIC COMPOUND | 住友化学株式会社 | 2022-10-27 | — | — | WO | claimed |
| EP-4061131-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING FATTY ACIDS | Bayer Aktiengesellschaft (DE) | 2022-09-28 | — | — | EP | claimed |
| EP-4013223-A1 | MATERIAL DELIVERY SYSTEMS AND METHODS | FMC Corporation (US) | 2022-06-22 | — | — | EP | claimed |
| CN-114401633-A | Pest control method, pest control agent composition, and pest control agent set | 日本曹达株式会社 | 2022-04-26 | — | — | CN | claimed |
| EP-0939073-B1 | Ester of 2,2-dimethyl-cyclopropanecarboxylic acid and their use as pesticides | SUMITOMO CHEMICAL CO (JP) | 2002-12-04 | — | — | EP | claimed |
| US-6225495-B1 | PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-05-01 | — | — | US | claimed |
| CN-116969925-B | Heteroaryl-triazole compounds | BAYER AG (DE) | 2026-05-26 | — | — | CN | disclosed |
| US-20260137083-A1 | HETEROCYCLYL PYRIDAZINE AS FUNGICIDAL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 2026-05-21 | — | — | US | disclosed |
| EP-4734762-A1 | BAIT COMPOSITIONS | FMC Corporation (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12616081-B2 | High precision greenhouse seed and seedling treatment | SYNGENTA CROP PROTECTION AG (CH) | 2026-05-05 | — | — | US | disclosed |
| US-12612386-B2 | Heteroaryl-triazole compounds as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2026-04-28 | — | — | US | disclosed |
| US-20220033374-A1 | SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-02-03 | — | — | US | disclosed |
| US-11124633-B2 | All temperature water borne sealant | RED DEVIL, INC. (US) | 2021-09-21 | — | — | US | disclosed |
| CN-112384566-A | Full temperature aqueous sealant | 红魔鬼公司 | 2021-02-19 | — | — | CN | disclosed |
| EP-2670246-B1 | PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING PESTS | SUMITOMO CHEMICAL CO (JP) | 2017-10-04 | — | — | EP | disclosed |
| US-20130303610-A1 | PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING PESTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303610-A1 | PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING PESTS | DDT, SGMS1, ACHE | TDP1 2913/4885MEN1 1212/4885KMT2A 90/4885 |
| US-12612386-B2 | Heteroaryl-triazole compounds as pesticides | CBR3, CYCS, HCN1 | TDP1 1856/4885MEN1 3011/4885KMT2A 3532/4885 |
| US-12616081-B2 | High precision greenhouse seed and seedling treatment | DCX, MYB, CROCC | TDP1 3774/4885MEN1 4529/4885KMT2A 4512/4885 |
| US-20220033374-A1 | SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS | TST, XDH, PGLS | TDP1 643/4885MEN1 4646/4885KMT2A 3745/4885 |
| US-20260137083-A1 | HETEROCYCLYL PYRIDAZINE AS FUNGICIDAL COMPOUNDS | CBR1, CBR3, CYC1 | TDP1 2999/4885MEN1 2137/4885KMT2A 2563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.